Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Atlas closes $280M life sciences-only fund

    Atlas Venture closed its oversubscribed $280 million Atlas Fund X, the firm's first fund since becoming an exclusively life sciences-focused VC.Formerly a hybrid firm, Atlas separated its tech and life sciences teams …

    Published on 4/17/2015
  • FINANCIAL NEWS: Follow-on roundup: Horizon, Akebia

    Horizon Pharma plc (NASDAQ:HZNP) raised $433.6 million through the sale of 15.4 million shares at $28.25 in a follow-on underwritten by Citigroup; Jefferies; Cowen; and Morgan Stanley. Horizon proposed the offering …

    Published on 4/17/2015
  • FINANCIAL NEWS: KemPharm raises $56 million in IPO

    KemPharm Inc. (NASDAQ: KMPH) gained $0.20 to $11.20 in its first day of trading after it raised $56 million in an IPO through the sale of 5.1 million shares at $11. The IPO price values KemPharm at $148.1 million. Cowen…

    Published on 4/16/2015
  • FINANCIAL NEWS: Cidara raises $76.8M in bumped-up IPO

    Anti-infective play Cidara Therapeutics Inc. (NASDAQ:CDTX) was unchanged at $16 in its first day of trading on Wednesday after raising $76.8 million in an IPO through the sale of 4.8 million shares at $16. The offering …

    Published on 4/15/2015
  • FINANCIAL NEWS: Follow-on roundup: Sage, Foamix

    Sage Therapeutics Inc. (NASDAQ:SAGE) and Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) raised a combined $180 million in follow-on offerings on Wednesday. Sage raised $120 million through the sale of 2.3 million shares at $…

    Published on 4/15/2015
  • FINANCIAL NEWS: NEA raises $3.2B for two funds

    New Enterprise Associates raised a total of $3.2 billion for two funds, including $2.8 billion for NEA 15 and $350 million for an adjunct fund, NEA 15 Opportunity Fund. The firm had targeted $2.5 billion for NEA 15 (see…

    Published on 4/15/2015
  • FINANCIAL NEWS: XBiotech raises $76M in IPO

    XBiotech Inc. (NASDAQ:XBIT) gained $4.25 (22%) to $23.25 in its first day of trading Wednesday after raising $76 million in an IPO through the sale of 4 million shares at $19. The price, which was the middle of the …

    Published on 4/15/2015
  • FINANCIAL NEWS: Merus Labs raises C$60M in bought deal

    Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI) raised C$60 million (US$47.5 million) on Monday through the sale of 19.7 million shares at C$3.05 to underwriters in a bought deal. Clarus Securities; Cormark …

    Published on 4/14/2015
  • FINANCIAL NEWS: Venture tracks

    Venture firm Truffle Capital promoted Antoine Pau to partner. Pau had been an investment director.

    Published on 4/14/2015
  • FINANCIAL NEWS: TVM raises $50M toward China fund

    TVM Capital Life Science announced a first close of $50 million for its China BioPharma Capital I fund, which the firm plans to invest in Western companies that intend to obtain licenses to develop and commercialize …

    Published on 4/13/2015
  • FINANCIAL NEWS: Venture tracks

    MPM Capital hired Gregory Sieczkiewicz as managing director and chief counsel for intellectual property. Sieczkiewicz was VP of intellectual property at Flagship Ventures.

    Published on 4/13/2015
  • FINANCIAL NEWS: Voyager raises $60M in series B

    Voyager Therapeutics Inc. (Cambridge, Mass.) raised $60 million in an untranched series B round led by new investors Brookside Capital and Partner Fund Management. Wellington Management; Casdin Capital; and two …

    Published on 4/13/2015
  • FINANCIAL NEWS: uniQure raises $88.5M in follow-on

    Gene therapy company uniQure N.V. (NASDAQ:QURE) raised $88.5 million through the sale of 3 million shares at $29.50 in a follow-on underwritten by Leerink; Cowen; Piper Jaffray; Oppenheimer; and H.C. Wainwright. uniQure…

    Published on 4/10/2015
  • FINANCIAL NEWS: Edge raises $72.5M in additional series C rounds

    Neurology company Edge Therapeutics Inc. (Berkeley Heights, N.J.) raised a combined $72.5 million in series C-1 and C-2 rounds. Edge raised $56 million this month in a C-2 round led by Venrock. Sofinnova Ventures; …

    Published on 4/9/2015
  • FINANCIAL NEWS: Woodford raises fund ceiling to L800M

    Woodford Investment Management LLP raised the ceiling of its Woodford Patient Capital Trust plc fund to L800 million ($1.2 billion) from L500 million ($746.6 million), after exceeding its initial target of L200 million…

    Published on 4/9/2015
  • FINANCIAL NEWS: Alzheon raises $10M in series A round

    Alzheon Inc. (Framingham, Mass.) raised $10 million in a series A round led by new investor Ally Bridge Group. Undisclosed new and existing investors also participated. CEO Martin Tolar told BioCentury the company hopes…

    Published on 4/8/2015
  • FINANCIAL NEWS: Carbylan raises $65M in downsized IPO

    Carbylan Therapeutics Inc. (NASDAQ:CBYL) raised $65 million through the sale of 13 million shares at $5 in a downsized IPO on Wednesday. The price values the company at $121.2 million. In January, Carbylan proposed to …

    Published on 4/8/2015
  • FINANCIAL NEWS: Follow-on roundup: Dyax, Prothena

    Dyax Corp. (NASDAQ:DYAX) and Prothena Corp. plc (NASDAQ:PRTA) raised $321.9 million in follow-on offerings on Wednesday.Dyax raised $199.8 million through the sale of 7.4 million shares at $27 in a deal underwritten by …

    Published on 4/8/2015
  • FINANCIAL NEWS: SanBio falls on first trading day

    Cell therapy company SanBio Co. Ltd. (Tokyo:4592) fell Y227 (11%) to Y1,773 in its first day of trading Wednesday after raising Y8 billion ($67.2 million) through the sale of 4 million shares at Y2,000 in an IPO. SanBio…

    Published on 4/8/2015
  • FINANCIAL NEWS: Ark Biosciences raises series A round

    Antiviral company Ark Biosciences Inc. (Shanghai, China) raised a series A round of undisclosed size. New investors Qiming Venture Partners and Morningside led the round, and existing investor TF Capital also …

    Published on 4/7/2015
  • FINANCIAL NEWS: Cerulean raises $35M in follow-on

    Oncology company Cerulean Pharma Inc. (NASDAQ:CERU) raised $35 million through the sale of 5.8 million shares at $6 in a follow-on underwritten by Leerink; Barclays; Canaccord Genuity; JMP Securities; and Wedbush …

    Published on 4/7/2015
  • FINANCIAL NEWS: Loncar unveils cancer immunotherapy index

    Loncar Investments LLC launched the Loncar Cancer Immunotherapy Index (LCINDX), an equal-weighted index that tracks the performance of 25 biopharma companies developing or marketing cancer immunotherapies. The index …

    Published on 4/7/2015
  • FINANCIAL NEWS: Nabriva raises $50M

    Nabriva Therapeutics AG (Vienna, Austria) raised $50 million in the first tranche of a planned $120 million series B round. New investors Vivo Capital and OrbiMed led the round. New investors EcoR1 Capital and Boxer …

    Published on 4/7/2015
  • FINANCIAL NEWS: Natera raises $55.5M series F round

    Diagnostics company Natera Inc. (San Carlos, Calif.) raised $55.5 million in a series F round led by Sofinnova Ventures. Capital Research and Management; Franklin Templeton Investments; Jennison Associates; RA Capital; …

    Published on 4/6/2015
  • FINANCIAL NEWS: Caribou raises $11M in series A

    Gene editing company Caribou Biosciences Inc. (Berkeley, Calif.) raised $11 million in an untranched series A round from Fidelity Bioscience; Novartis; Mission Bay Capital; 5 Prime Ventures; and an undisclosed strategic…

    Published on 4/2/2015

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993